Recent advances in cardiovascular risk assessment: The added value of non-invasive anatomic imaging

J Cardiovasc Comput Tomogr. 2024 Mar-Apr;18(2):113-119. doi: 10.1016/j.jcct.2024.01.012. Epub 2024 Feb 6.

Abstract

In 2022, multiple original research studies were conducted highlighting the utility of coronary artery calcium (CAC) imaging in young individuals and provided further evidence for the role of CAC to improve atherosclerotic cardiovascular disease (ASCVD) risk assessment. Mean calcium density was shown to be a more reliable predictor than peak density in risk assessment. Additionally, in light of the ACC/AHA/Multispecialty Chest Pain Guideline's recent elevation of coronary computed tomography angiography (CCTA) to a Class I (level of evidence A) recommendation as an index diagnostic test for acute or stable chest pain, several studies support the utility of CCTA and guided future directions. This review summarizes recent studies that highlight the role of non-invasive imaging in enhancing ASCVD risk assessment across different populations.

Keywords: ASCVD; Coronary CTA; Coronary artery calcium; Coronary artery disease; Prevention.

Publication types

  • Review

MeSH terms

  • Atherosclerosis*
  • Calcium
  • Cardiovascular Diseases* / diagnostic imaging
  • Chest Pain
  • Coronary Angiography / methods
  • Coronary Artery Disease* / diagnostic imaging
  • Heart Disease Risk Factors
  • Humans
  • Predictive Value of Tests
  • Risk Assessment
  • Risk Factors
  • Vascular Calcification* / diagnostic imaging

Substances

  • Calcium